32
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Use of doxycycline for leptospirosis after high-risk exposure in São Paulo, Brazil

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A clinical trial pilot study, double-blinded, randomized, and controlled with a placebo to assess the effectiveness of oral doxycycline (200 mg, single dose) in preventing leptospirosis after high exposure to potentially contamined water was performed in São Paulo, SP, Brazil. Confirmed cases were defined as those with leptospira IgM antibody and symptoms; asymptomatic cases were those presenting with IgM antibodies but no symptoms; and suspected cases were individuals with symptoms but no IgM antibody. Forty subjects were given doxycycline and 42 were given placebo. In the drug-treated group there were 2 confirmed cases, 11 asymptomatic cases, and 6 suspected cases. In the placebo group there were 5 confirmed, 6 symptomatic, and 5 suspected cases. Even though we found a protective association of doxycycline for confirmed leptospirosis cases (RR = 2.3) and seroconversion only (RR = 2.0), the association was not statistically significant because of the small number of individuals enrolled in this pilot study. We observed that the 22% of the volunteers already had IgM antibodies to leptospirosis at the first sampling. Finally, the attack rate to confirmed, asymptomatic, and suspected cases of Leptospirosis was 8.5%, 22%, and 13%, respectively, in this population.

          Translated abstract

          Um ensaio clínico, duplo-cego, ao acaso, e controlado com placebo para aferir a eficácia da doxiciclina (200 mg, dose única) em prevenir leptospirose após exposição de alto risco com água potencialmente contaminada foi realizado em São Paulo, SP, Brasil. Casos confirmados foram definidos como aqueles que apresentavam anticorpos IgM anti-Leptospira e sintomas; casos assintomáticos eram aqueles que apresentavam somente anticorpo IgM, casos suspeitos apresentavam sintomas, porém sem anticorpo IgM. 40 indivíduos tomaram doxaciclina e 42 tomaram placebo. No grupo tratado houve 2 casos confirmados, 11 assintomáticos e 6 casos suspeitos. No grupo placebo houve 5 casos confirmados, 6 assintomáticos e 5 casos suspeitos. Apesar de haver uma associação protetora da doxaciclina nos casos confirmados (RR = 2,3) e soroconversão (RR = 2,0), a associação não foi estatisticamente significante devido ao pequeno número de indivíduos envolvidos no estudo. Foi observado que a taxa de ataque de casos confirmados, casos assintomáticos e casos suspeitos de leptospirose foi 8,5%, 22%, e 13%, nessa população.

          Related collections

          Most cited references13

          • Record: found
          • Abstract: not found
          • Article: not found

          Leptospirosis

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            An efficacy trial of doxycycline chemoprophylaxis against leptospirosis.

            Because leptospirosis has been an important cause of morbidity in U.S. soldiers training in the Republic of Panama, we conducted a randomized, double-blind, placebo-controlled field trial during the fall of 1982 to determine whether doxycycline was an effective chemoprophylactic agent against this infection. Doxycycline (200 mg) or placebo was administered orally on a weekly basis and at the completion of training to 940 volunteers from two U.S. Army units deployed in Panama for approximately three weeks of jungle training. Twenty cases of leptospirosis occurred in the placebo group (an attack rate of 4.2 per cent), as compared with only one case in the doxycycline group (attack rate, 0.2 per cent, P less than 0.001), yielding an efficacy of 95.0 per cent. This study demonstrated the value of doxycycline as a prophylactic drug against leptospirosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Doxycycline therapy for leptospirosis.

              To study antibiotic efficacy, 29 patients with leptospirosis were treated in a randomized, double-blinded fashion with doxycycline, 100 mg orally twice a day, or placebo. Therapy was given for 7 days in a hospital, and patients were followed for 3 weeks afterwards. Duration of illness before therapy and severity of illness were the same in both groups. Doxycycline reduced the duration of illness by 2 days and favorably affected fever, malaise, headache, and myalgias. Treatment prevented leptospiruria and had no adverse effects. Doxycycline is effective in therapy for patients with leptospirosis.
                Bookmark

                Author and article information

                Journal
                rimtsp
                Revista do Instituto de Medicina Tropical de São Paulo
                Rev. Inst. Med. trop. S. Paulo
                Instituto de Medicina Tropical (São Paulo, SP, Brazil )
                1678-9946
                January 1998
                : 40
                : 1
                : 59-61
                Affiliations
                [01] orgnameInstitute of Infectious Diseases Emílio Ribas
                [02] orgnameAdolfo Lutz Institute
                [03] orgname orgdiv1 PAM Jacanã
                Article
                S0036-46651998000100012 S0036-4665(98)04000112
                10.1590/S0036-46651998000100012
                9713140
                a3a556ab-eb8a-4992-9966-4cc26cd2d4b8

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 08 August 1997
                : 23 December 1997
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 8, Pages: 3
                Product

                SciELO Brazil

                Categories
                Therapeutic Trial

                Leptospirosis control,Incidence,Doxycycline,Brazil,São Paulo

                Comments

                Comment on this article